Pelvic lymphadenectomy for muscle invasive urothelial carcinoma: extended morbidity for limited benefit?
Transl Androl Urol
.
2019 Mar;8(Suppl 1):S104-S105.
doi: 10.21037/tau.2018.12.11.
Authors
Omid Yassaie
1
,
Matthew J Roberts
2
3
,
Marlon Perera
2
3
Affiliations
1
Department of Urology, Auckland Hospital, Auckland, New Zealand.
2
Faculty of Medicine, The University of Queensland, Brisbane, Australia.
3
Department of Urology, Princess Alexandra Hospital, Brisbane, Australia.
PMID:
31143681
PMCID:
PMC6511696
DOI:
10.21037/tau.2018.12.11
No abstract available
Publication types
Editorial
Comment